Purpose: To evaluate the diagnostic accuracy of PET with different radiotracers and
parameters in differentiating between true glioma progression (TPR) and post treatment …

Glioblastoma multiforme (GBM) is the most common and aggressive form of the primary
brain tumors in humans. The intricate pathophysiology, the development of resistance by …

Aim: In this comprehensive review we present an update on the most relevant studies
evaluating the utility of amino acid PET radiotracers for the evaluation of glioma recurrence …

Imaging plays a critical role in the management of the highly complex and widely diverse
central nervous system (CNS) malignancies in providing an accurate diagnosis, treatment …

Despite the advancement of neuroimaging techniques, it often remains a diagnostic
challenge to distinguish recurrent glioma from lesions representing treatment effect …

Background/Aim: Gliomas are the most common and recalcitrant malignant primary brain
tumors. All cancer types are addicted to methionine, which is a fundamental and general …

Based on studies focusing on positron emission tomography (PET)-computed tomography
(CT) combined with magnetic resonance imaging (MRI) in the diagnosis of glioma, we …

Pathological alterations in cell functions are frequently accompanied by metabolic
reprogramming including modifications in amino acid metabolism. Amino acid detection is …

The present most common image diagnostic tracer in clinical practice for glioma is 18F-
fluorodeoxyglucose (FDG) positron emission tomography (PET) for brain tumors diagnosis …

Purpose Primary central nervous system lymphoma (PCNSL) has a poor prognosis. There
has been limited study evaluating the role of interim PET/CT in PCNSL. This prospective …